Regeneron Pharmaceuticals Down 30.5% Since SmarTrend Downtrend Call (REGN)

SmarTrend identified a Downtrend for Regeneron Pharmaceuticals (NASDAQ:REGN) on December 14th, 2015 at $533.74. In approximately 2 months, Regeneron Pharmaceuticals has returned 30.49% as of today's recent price of...